Brooks Michael J 4

What Happened
Michael J. Brooks, President of Edesa Biotech, acquired 2,000 shares on February 26, 2026. The filing reports a purchase price of $1.57 per share for a total transaction value of $3,140. This was a purchase (insider buy), which investors often view as a more informative signal than routine sales.

Key Details

• Transaction date: 2026-02-26; reported on Form 4 filed 2026-03-11 (filed late relative to the 2-business-day rule).
• Price and quantity: 2,000 shares at $1.57 each; total ≈ $3,140.
• Transaction type: Purchase (listed as "open market or private purchase" in the filing).
• Shares owned after transaction: Not disclosed in the Form 4.
• Footnotes/plans: No 10b5‑1 plan, tax withholding, or other special footnotes noted in the reported transaction.

Context
Insider purchases can indicate confidence but do not prove future performance—no motive is stated. The Form 4 was filed on 2026-03-11 for a 2026-02-26 trade, which is later than the typical 2-business-day reporting window; late filing can limit timely transparency for investors.